Dec 15, 2025 06:06AM Truist Securities Starts Septerna Inc (SEPN) at Buy

Nov 21, 2025 06:56AM Septerna's (SEPN) Novo Pursuing a Multi-Billion-Dollar Opportunity- Cantor Fitzgerald

Nov 11, 2025 07:43AM Septerna Inc (SEPN) Reiterated at Overweight by Cantor Fitzgerald

Nov 10, 2025 05:18PM Septerna, Inc. (SEPN) Tops Q3 EPS by 83c

Aug 22, 2025 06:58AM H.C. Wainwright Reiterates Buy Rating on Septerna Inc (SEPN)

Aug 11, 2025 04:45PM Septerna, Inc. (SEPN) Tops Q2 EPS by 7c

May 16, 2025 07:02AM Septerna, Inc. (SEPN) Tops Q1 EPS by 5c

May 16, 2025 06:43AM Septerna Inc (SEPN) PT Raised to $25 at Cantor Fitzgerald

May 15, 2025 05:59AM Septerna (SEPN) call put ratio 1.6 calls to 1 put amid wide price movement

May 14, 2025 07:03AM Septerna (SEPN) and Novo Nordisk (NVO) to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases

Feb 18, 2025 09:57AM JPMorgan Reiterates Overweight Rating on Septerna Inc (SEPN), PT $38, 'we remain buyers of SEPN'

Feb 18, 2025 08:00AM Septerna (SEPN) Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist

Feb 18, 2025 07:56AM Septerna (SEPN) Halted, News Pending

Feb 11, 2025 06:42AM Cantor Fitzgerald Reiterates Overweight Rating on Septerna Inc (SEPN)

Jan 6, 2025 07:01AM Septerna (SEPN) Expands Leadership with Appointment of Industry Veteran Gil Labrucherie as Chief Financial Officer

Nov 19, 2024 06:36AM Cantor Fitzgerald Starts Septerna Inc (SEPN) at Overweight

Nov 19, 2024 05:36AM TD Cowen Starts Septerna Inc (SEPN) at Buy

Nov 19, 2024 03:35AM JPMorgan Starts Septerna Inc (SEPN) at Overweight

Oct 25, 2024 06:06AM Septerna (SEPN) Prices Upsized 16M Share IPO at $18/sh

Oct 24, 2024 07:58AM Septerna (SEPN) Files for 15.28M Share IPO at $18/sh

Oct 21, 2024 06:14AM Septerna (SEPN) Files 10.94M Share IPO at $15-$17/sh

Oct 2, 2024 04:28PM Septerna (SEPN) Files for Proposed IPO